2017年7月5日，南京医科大学附属淮安第一人民医院神经外科在Oncology Research（中科院四区 IF=2）期刊上在线发表题为 "Overexpression of Protease Serine 8 Inhibits Glioma ...

Firefighters show higher rates of glioma-linked SBS42 mutational signatures associated with haloalkane exposure, suggesting ...

A study shows that high-grade glioma tumor cells harboring DNA alterations in the gene PDGFRA responded to the drug avapritinib, which is already approved by the United States Food and Drug ...

Firefighters may face a heightened risk of developing brain cancer due to their persistent exposure to certain chemicals, a ...

The detailed molecular characterization of malignant glioma and medulloblastoma has not only more accurately defined specific subgroupings in individual morphological categories, but has also laid ...

New research by Yale has found an association between exposure to chemicals commonly used in firefighting and incidence of a brain tumor called a glioma in firefights, suggesting that the cancer may ...

A new study published in the journal of Menopause found that overall, among menopausal women, the usage and duration of ...

A new study uncovered an association between exposure to chemicals commonly used in firefighting and glioma risk, reinforcing ...

Scientists at UCLA have discovered a potential new way to treat glioblastoma, the most aggressive type of brain cancer. Their ...

Gene mutations caused by exposure to certain chemical compounds have been linked to the development of gliomas, the most common type of malignant brain tumor.

Chimerix’s lead clinical pipeline candidate is dordaviprone, a first-in-class small molecule treatment designed to selectively target the mitochondrial protease ClpP and dopamine receptor D2 (DRD2).